 "NTAGI analyses data of breakthrough infections to decide on booster dose")
To make a decision regarding a booster dose of the COVID-19 vaccine, the National Technical Advisory Group on Immunisation (NTAGI) is analyzing data of COVID-19 breakthrough infections in India, said sources on Tuesday.
As per the sources, "NTAGI is analyzing data of COVID-19 breakthrough infections in India, to look at the vaccine effectiveness and take a decision regarding additional and booster dose."
During its last meeting, the NTAGI had made no final recommendation on additional COVID-19 vaccine doses and vaccines for children. However, both the issues were discussed in the meeting and the booster dose was not on the agenda of today's meeting.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)